การจำลองการฉายรังสีด้วยภาพสะท้อนในสนามแม่เหล็ก (MRI simulation)
References
Ling CC, Fuks Z. Conformal radiation treatment: A critical appraisal. Eur J Cancer. 1995;31:799-803.
Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol. 1999;9:78-98.
Kondziolka D., McDermott M., Régis Marseille J., Smee R., Flickinger JC. Radiosurgery; v. 6. In: Kondziolka D. editor. 7th International Stereotactic Radiosurgery Society Meeting, Brussels; 2005 September 11–15; Basel, Switzerland. Basel: Karger, 2006.
Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996;23:1641-74.
Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology. 1999;213:473-80.
Nguyen ML, Willows B, Khan R, Chi A, Kim A, Nour SG, et al. The potential role of magnetic resonance spectroscopy in image-guided radiotherapy. Front. Oncol 2014;4:1-6.
Pautler RG. Mouse MRI: Concepts and Applications in Physiology. Physiology. 2004;19:168-175.
Baker HI., Berquist TH., Kispert DB., Reese DF., Houser OW., Earnest F., et al. Magnetic Resonance Imaging in a Routine Clinical Setting. Mayo Clinic Proceedings. 1985;60:75-90.
Aoyama H, Shirato H, Nishioka T, Hashimoto S, Tsuchiya K, Kagei K, et al. Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. Int J Radiat Oncol Biol Phys. 2001;50:821-7.
Khoo VS, Adams EJ, Saran F, Bedford JL, Perks JR, Warrington AP, et al. A comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas. Int J Radiat Oncol Biol Phys. 2000;46:1309-17.
Dhermain F. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches. Chin J Cancer. 2014;33:16-24.
Narayana A, Chang J, Thakur S, Huang W, Karimi S, Hou B, et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol. 2007;80:347-54.
Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys. 2001;50:915-28.
Chung NN, Ting LL, Hsu WC, Lui LT, Wang PM. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck. 2004;26:241-6.
Emami B1, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:481-8.
Filip GC, Hedvig H, Robert RH. Pretreatment evaluation of prostate cancer. Role of MR imaging and 1H MR spectroscopy. Radiographics. 2004;24:167–80.
Roach M, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1996;35:1011-8.
Debois M, Oyen R, Maes F, Verswijvel G, Gatti G, Bosmans H, et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys. 1999;45:857-65.
Sannazzari GL, Ragona R, Ruo Redda MG, Giglioli FR, Isolato G, Guarneri A. CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol. 2002;75:603-7.
Steenbakkers RJ, Deurloo KE, Nowak PJ, Lebesque JV, van Herk M, Rasch CR. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2003;57:1269-79.
Sefrova J, Odrazka K, Paluska P, Belobradek Z, Brodak M, Dolezel M, et al. Magnetic resonance imaging in postprostatectomy radiotherapy planning. Int J Radiat Oncol Biol Phys. 2012;82:911-8.
Tan J, Lim Joon D, Fitt G, Wada M, Lim Joon M, Mercuri A, et al. The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study. J Med Imaging Radiat Oncol. 2010;54:562-8.
Gwynne S, Mukherjee S, Webster R, Spezi E, Staffurth J, Coles B, et al. Imaging for target volume delineation in rectal cancer radiotherapy--a systematic review. Clin Oncol (R Coll Radiol). 2012;24:52-63.
Wang YY, Zhe H. Clinical application of multimodality imaging in radiotherapy treatment planning for rectal cancer. Cancer Imaging. 2013;13:495-501.
Russell AH, Walter JP, Anderson MW, Zukowski CL. Sagittal magnetic resonance imaging in the design of lateral radiation treatment portals for patients with locally advanced squamous cancer of the cervix. Int J Radiat Oncol Biol Phys. 1992;23:449-55.
Barillot I, Reynaud-Bougnoux A. The use of MRI in planning radiotherapy for gynaecological tumours. Cancer Imaging. 2006;6:100-6.
Pötter R, George P, Dimopoulus J, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100:116-23.
Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol. 2012;103:305-13.
Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235-45.
Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D imagebased anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67-77.
Dimopoulos JC, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012;103:113-22.
Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol. 1999;9:78-98.
Kondziolka D., McDermott M., Régis Marseille J., Smee R., Flickinger JC. Radiosurgery; v. 6. In: Kondziolka D. editor. 7th International Stereotactic Radiosurgery Society Meeting, Brussels; 2005 September 11–15; Basel, Switzerland. Basel: Karger, 2006.
Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996;23:1641-74.
Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology. 1999;213:473-80.
Nguyen ML, Willows B, Khan R, Chi A, Kim A, Nour SG, et al. The potential role of magnetic resonance spectroscopy in image-guided radiotherapy. Front. Oncol 2014;4:1-6.
Pautler RG. Mouse MRI: Concepts and Applications in Physiology. Physiology. 2004;19:168-175.
Baker HI., Berquist TH., Kispert DB., Reese DF., Houser OW., Earnest F., et al. Magnetic Resonance Imaging in a Routine Clinical Setting. Mayo Clinic Proceedings. 1985;60:75-90.
Aoyama H, Shirato H, Nishioka T, Hashimoto S, Tsuchiya K, Kagei K, et al. Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. Int J Radiat Oncol Biol Phys. 2001;50:821-7.
Khoo VS, Adams EJ, Saran F, Bedford JL, Perks JR, Warrington AP, et al. A comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas. Int J Radiat Oncol Biol Phys. 2000;46:1309-17.
Dhermain F. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches. Chin J Cancer. 2014;33:16-24.
Narayana A, Chang J, Thakur S, Huang W, Karimi S, Hou B, et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol. 2007;80:347-54.
Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys. 2001;50:915-28.
Chung NN, Ting LL, Hsu WC, Lui LT, Wang PM. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck. 2004;26:241-6.
Emami B1, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:481-8.
Filip GC, Hedvig H, Robert RH. Pretreatment evaluation of prostate cancer. Role of MR imaging and 1H MR spectroscopy. Radiographics. 2004;24:167–80.
Roach M, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1996;35:1011-8.
Debois M, Oyen R, Maes F, Verswijvel G, Gatti G, Bosmans H, et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys. 1999;45:857-65.
Sannazzari GL, Ragona R, Ruo Redda MG, Giglioli FR, Isolato G, Guarneri A. CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol. 2002;75:603-7.
Steenbakkers RJ, Deurloo KE, Nowak PJ, Lebesque JV, van Herk M, Rasch CR. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2003;57:1269-79.
Sefrova J, Odrazka K, Paluska P, Belobradek Z, Brodak M, Dolezel M, et al. Magnetic resonance imaging in postprostatectomy radiotherapy planning. Int J Radiat Oncol Biol Phys. 2012;82:911-8.
Tan J, Lim Joon D, Fitt G, Wada M, Lim Joon M, Mercuri A, et al. The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study. J Med Imaging Radiat Oncol. 2010;54:562-8.
Gwynne S, Mukherjee S, Webster R, Spezi E, Staffurth J, Coles B, et al. Imaging for target volume delineation in rectal cancer radiotherapy--a systematic review. Clin Oncol (R Coll Radiol). 2012;24:52-63.
Wang YY, Zhe H. Clinical application of multimodality imaging in radiotherapy treatment planning for rectal cancer. Cancer Imaging. 2013;13:495-501.
Russell AH, Walter JP, Anderson MW, Zukowski CL. Sagittal magnetic resonance imaging in the design of lateral radiation treatment portals for patients with locally advanced squamous cancer of the cervix. Int J Radiat Oncol Biol Phys. 1992;23:449-55.
Barillot I, Reynaud-Bougnoux A. The use of MRI in planning radiotherapy for gynaecological tumours. Cancer Imaging. 2006;6:100-6.
Pötter R, George P, Dimopoulus J, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100:116-23.
Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol. 2012;103:305-13.
Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235-45.
Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D imagebased anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67-77.
Dimopoulos JC, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012;103:113-22.
Downloads
Published
2015-06-29
How to Cite
1.
ส่งทอง อ, สุริยาปี ศ, เลิศบุษยานุกูล ช, จักกาบาตร์ จ, ขอประเสริฐ ช. การจำลองการฉายรังสีด้วยภาพสะท้อนในสนามแม่เหล็ก (MRI simulation). J Thai Assn of Radiat Oncol [Internet]. 2015 Jun. 29 [cited 2024 Nov. 15];21(1):31-45. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/203279
Issue
Section
Original articles
License
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารมะเร็งวิวัฒน์ ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับ และบุคคลากรท่านอื่น ๆ ใน สมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใดๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
